IL149398A0 - USE OF RUSSELL'S VIPER VENOM-INDUCED PLASMA FACTOR Xa ACTIVITY TO MONITOR THE ACTIVITY OF FACTOR Xa INHIBITORS - Google Patents

USE OF RUSSELL'S VIPER VENOM-INDUCED PLASMA FACTOR Xa ACTIVITY TO MONITOR THE ACTIVITY OF FACTOR Xa INHIBITORS

Info

Publication number
IL149398A0
IL149398A0 IL14939800A IL14939800A IL149398A0 IL 149398 A0 IL149398 A0 IL 149398A0 IL 14939800 A IL14939800 A IL 14939800A IL 14939800 A IL14939800 A IL 14939800A IL 149398 A0 IL149398 A0 IL 149398A0
Authority
IL
Israel
Prior art keywords
activity
factor
russell
inhibitors
monitor
Prior art date
Application number
IL14939800A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930535.1A external-priority patent/GB9930535D0/en
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL149398A0 publication Critical patent/IL149398A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
    • G01N2333/4613—Snake venom
    • G01N2333/4616—Snake venom from Russell's viper
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666—Carboxylic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14939800A 1999-11-02 2000-10-28 USE OF RUSSELL'S VIPER VENOM-INDUCED PLASMA FACTOR Xa ACTIVITY TO MONITOR THE ACTIVITY OF FACTOR Xa INHIBITORS IL149398A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16316199P 1999-11-02 1999-11-02
GBGB9930535.1A GB9930535D0 (en) 1999-12-23 1999-12-23 Method
PCT/EP2000/010646 WO2001033217A2 (en) 1999-11-02 2000-10-28 Monitoring the activity of factor xa inhibitors

Publications (1)

Publication Number Publication Date
IL149398A0 true IL149398A0 (en) 2002-11-10

Family

ID=26316147

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14939800A IL149398A0 (en) 1999-11-02 2000-10-28 USE OF RUSSELL'S VIPER VENOM-INDUCED PLASMA FACTOR Xa ACTIVITY TO MONITOR THE ACTIVITY OF FACTOR Xa INHIBITORS

Country Status (11)

Country Link
US (1) US7220553B2 (xx)
EP (1) EP1230382B1 (xx)
JP (1) JP4463460B2 (xx)
AT (1) ATE267876T1 (xx)
AU (1) AU1515701A (xx)
CA (1) CA2389747C (xx)
DE (1) DE60011128T2 (xx)
ES (1) ES2222250T3 (xx)
IL (1) IL149398A0 (xx)
MX (1) MXPA02003693A (xx)
WO (1) WO2001033217A2 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0705049B1 (pt) * 2007-12-28 2019-02-26 Embraco Indústria De Compressores E Soluções Em Refrigeração Ltda Compressor de gás movido por um motor linear, tendo um detector de impacto entre um cilindro e um pistão, método de detecção e sistema de controle
ES2620421T3 (es) * 2009-10-30 2017-06-28 Senova Gesellschaft für Biowissenschaft und Technik mbH Peptidasas acopladas a polímero
US20110136779A1 (en) * 2009-11-23 2011-06-09 Milner Peter G Methods for stroke reduction in atrial fibrillation patients
US9549912B2 (en) 2009-11-23 2017-01-24 Armetheon, Inc. Methods for treating atrial fibrillation
US20110144199A1 (en) * 2009-11-23 2011-06-16 Milner Peter G Methods for treating atrial fibrillation
EP2484775A1 (de) * 2011-02-07 2012-08-08 Siemens Healthcare Diagnostics Products GmbH Heparin-insensitives Verfahren zur Bestimmung von direkten Gerinnungsfaktorinhibitoren
ES2907190T3 (es) * 2014-07-31 2022-04-22 Haemonetics Corp Detección de la reversión de un anticoagulante mediante pruebas de coagulación por ecarina y factor Xa
CN108982865B (zh) * 2018-08-16 2021-05-11 上海原科实业发展有限公司 一种血栓弹力图法肝素定量检测试剂盒及其制备方法
CN114681597A (zh) * 2022-03-11 2022-07-01 兆科药业（合肥）有限公司 蝰蛇蛇毒血凝酶在制备用于逆转凝血因子Xa抑制剂的抗凝作用的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58189646A (ja) * 1982-04-01 1983-11-05 Canon Inc 磁性トナ−
US4946775A (en) * 1985-09-05 1990-08-07 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
US5120537A (en) * 1989-06-14 1992-06-09 Oklahoma Medical Research Foundation Factor xa based anticoagulant compositions
US5187155A (en) * 1989-06-23 1993-02-16 Board Of Regents, The University Of Texas System Anticoagulant peptides
US6103888A (en) * 1992-07-17 2000-08-15 Panorama Research, Inc. Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity
SK284507B6 (sk) 1996-01-02 2005-05-05 Aventis Pharmaceuticals Inc. Substituované N-[(aminoiminometyl)fenyl]propylamid alebo N-[(aminometyl)fenyl]propylamid, farmaceutický prostriedok s jeho obsahom a použitie
US5886191A (en) * 1997-08-18 1999-03-23 Dupont Pharmaceuticals Company Amidinoindoles, amidinoazoles, and analogs thereof

Also Published As

Publication number Publication date
CA2389747C (en) 2011-05-03
EP1230382B1 (en) 2004-05-26
US20030049704A1 (en) 2003-03-13
AU1515701A (en) 2001-05-14
ATE267876T1 (de) 2004-06-15
EP1230382A2 (en) 2002-08-14
ES2222250T3 (es) 2005-02-01
CA2389747A1 (en) 2001-05-10
US7220553B2 (en) 2007-05-22
WO2001033217A3 (en) 2001-11-29
WO2001033217A2 (en) 2001-05-10
DE60011128T2 (de) 2005-07-07
JP4463460B2 (ja) 2010-05-19
JP2003513280A (ja) 2003-04-08
DE60011128D1 (de) 2004-07-01
MXPA02003693A (es) 2003-10-14

Similar Documents

Publication Publication Date Title
DE69800637T2 (de) Auswahl von Grenzwerten für Patientenüberwachungssysteme
BR9908280A (pt) Inibidores de enzimas de fosfolipase
DE69906008D1 (de) Blutdruckmessgerät
IL149398A0 (en) USE OF RUSSELL'S VIPER VENOM-INDUCED PLASMA FACTOR Xa ACTIVITY TO MONITOR THE ACTIVITY OF FACTOR Xa INHIBITORS
DE19882746T1 (de) Enzymvermittelte Modifikation von Fibrin für das Gewebs-Engineering
AU2003303597A8 (en) Continuous glucose monitoring system and methods of use
WO2004032051A3 (en) Systems and methods for providing sensor fusion
GB0203446D0 (en) Detection and/or monitoring of synuclein-related diseases
DK1385423T3 (da) Udstyr til måling af glukosekoncentrationer i blod
NO983688L (no) Serin-protease-inhibitorer
NZ511927A (en) Phenylglycine derivatives
DE69924375D1 (de) Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms
DE69934934D1 (de) Gewebeklebstoff enthaltend ein Alkalimetall Salz von Carboxymethylcellulose , Fibrinogen und Thrombin
AU2002327308A1 (en) Methods for evaluating pathologic conditions using extracellular rna
BR9914648A (pt) Processo para monitorar ação medicamentosa deinibidor de proteasoma
MA27201A1 (fr) Composition pour le traitement de tissus a ajouter au rincage, procedes et utilisations associes"
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
BR9913705A (pt) Métodos de tratamento de mieloma múltiplo e reabsorção de tecido ósseo induzido por mieloma utilizando antagonistas de integrin
FI19992484A (fi) Menetelmä sykemittausjärjestelyn toiminta-asetusten suorittamiseksi ja sykemittausjärjestely
WO2002036580A3 (en) Benzoxazole lpaat- beta inhibitors and uses thereof
AU5628800A (en) Substituted benzamide inhibitors of rhinovirus 3c protease
AU6630101A (en) Chest piece for stethoscopes, and methods of utilizing stethoscopes for monitoring the physiological conditons of patient
WO2002100337A3 (en) Antithrombotic thrombin variants
JP2003513280A5 (xx)
DE69929389D1 (de) Nichtinvasiver Blutdruckwächter